Circio logoCircio logo

  • About
      • About Circio
      • CEO Statement
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share facts
      • Largest shareholders
      • Dividend policy
      • Analyst coverage
      • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Articles of Association
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • CEO Statement
      • Our pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Warrants exercise 2024
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share information
        • Share and trading information
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Articles of Association
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    • All press releases
    2024
    • 2026
    • 2025
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    All subjects
    • Corporate news
    • Other
    All languages
    • English
    • Norwegian
    December 19, 2024
    Press release - Regulatory

    Circio Holding ASA – Final results of the warrant exercise

    December 18, 2024
    Press release - Regulatory

    Circio raises NOK 10.7 million in upsized offering from new and existing shareholders

    December 18, 2024
    Press release - Regulatory

    Circio Holding ASA – Preliminary results of the warrant exercise

    December 18, 2024
    Press release - Regulatory

    Circio Holding ASA – Allocation of Available Warrants and Private Placement completed

    December 18, 2024
    Press release - Regulatory

    Circio Holding ASA – Last day of exercise period for warrants issued in July 2024

    December 17, 2024
    Press release - Regulatory

    Circio Holding ASA – Transfer of rights to warrants from primary insiders

    December 17, 2024
    Press release - Regulatory

    Circio Holding ASA – Application for additional warrants for the subscription of new shares by primary insider

    December 17, 2024
    Press release - Regulatory

    Circio Holding ASA – Application for additional warrants for the subscription of new shares by primary insider CEO Erik D Wiklund

    December 17, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of Warrants by primary insiders on the Board of Directors

    December 15, 2024
    Press release - Regulatory

    Circio Holding ASA – Invitation to receive Warrants and subscribe for new shares

    December 13, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of Warrants by primary insider

    December 11, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of Warrants by primary insider

    December 10, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of Warrants by primary insider

    December 9, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of Warrants by primary insider

    December 6, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    December 5, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    December 5, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of Warrants by primary insider CEO Erik D Wiklund

    December 4, 2024
    Press release - Non-regulatory

    Circio announces novel circVec 3.0 generation and circular mRNA half-life up to 75 times longer than linear mRNA in vivo

    December 4, 2024
    Press release - Regulatory

    Circio Holding ASA – Funding requested under financing commitment from Atlas

    December 4, 2024
    Press release - Regulatory

    Circio Holding ASA – Commencement of exercise period for warrants issued in July 2024

    December 2, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    November 28, 2024
    Press release - Non-regulatory

    Circio invites to R&D and corporate update webcast on 4 December 2024

    November 27, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    November 22, 2024
    Press release - Regulatory

    Circio announces allocation of stock options to key employees

    November 19, 2024
    Press release - Non-regulatory

    Circio announces circVec LNP-delivery collaboration with Certest progressing to in vivo testing

    November 14, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    November 12, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    November 5, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    November 1, 2024
    Press release - Regulatory

    Circio Holding ASA – Conversion of Convertible Bonds and funding requested under financing commitment from Atlas

    October 31, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    October 25, 2024
    Press release - Non-regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    October 25, 2024
    Press release - Non-regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    October 24, 2024
    Press release - Non-regulatory

    Circio presents circVec circular RNA in vivo expression proof-of-concept data at ESGCT 2024 annual meeting

    October 23, 2024
    Press release - Non-regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    September 24, 2024
    Press release - Non-regulatory

    Circio selected for oral presentation at ESGCT 2024 annual meeting

    August 29, 2024
    Press release - Regulatory

    Circio Holding ASA: First half 2024 results

    August 26, 2024
    Press release - Non-regulatory

    Circio Holding ASA: Invitation to first half-year 2024 presentation on Thursday 29 August at 10:00am CEST

    August 12, 2024
    Press release - Regulatory

    Circio Holding ASA – NOK 1.5m requested from Atlas under NOK 10m rights issue commitment

    July 26, 2024
    Press release - Regulatory

    Circio Holding ASA – Information about the warrants issued in connection with the rights issue and new share capital registered

    July 9, 2024
    Press release - Regulatory

    Circio Holding ASA – Mandatory notification of trade by primary insiders and close associates related to the rights issue

    July 9, 2024
    Press release - Regulatory

    Circio Holding ASA – Final results of the rights issue

    July 8, 2024
    Press release - Regulatory

    Circio Holding ASA – Preliminary results of the rights issue

    July 8, 2024
    Press release - Regulatory

    Circio Holding ASA – Last day of the subscription period in the rights issue

    July 5, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders

    July 3, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders

    July 2, 2024
    Press release - Regulatory

    Circio Holding ASA – Last day of trading in subscription rights in the rights issue

    June 28, 2024
    Press release - Regulatory

    Circio Holding ASA – Exercise of subscription rights in the rights issue by primary insiders

    June 26, 2024
    Press release - Non-regulatory

    Circio Holding ASA – Link to online subscription in the rights issue

    June 26, 2024
    Press release - Regulatory

    Circio invited to present circVec circular RNA technology at upcoming international RNA therapeutics conferences

    June 25, 2024
    Press release - Non-regulatory

    Circio´s leading position in circular RNA therapeutics highlighted by broad recent coverage in international life science industry media

    June 24, 2024
    Press release - Regulatory

    Circio Holding ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates

    June 24, 2024
    Press release - Regulatory

    Circio Holding ASA – Commencement for the subscription period for the rights issue

    June 20, 2024
    Press release - Regulatory

    Circio Holding ASA – Ex. subscription rights today

    June 19, 2024
    Press release - Regulatory

    Circio Holding ASA – Minutes from the annual general meeting 2024 and approval of Rights Issue

    June 18, 2024
    Press release - Regulatory

    Circio Holding ASA – Approval and publication of prospectus for the rights issue

    June 18, 2024
    Press release - Regulatory

    Circio Holding ASA – Updated key information relating to the rights issue

    June 18, 2024
    Press release - Regulatory

    Circio Holding ASA – Updated information to the notice of annual general meeting 2024

    June 17, 2024
    Press release - Non-regulatory

    Circio announces strengthened in vivo data and enhanced circVec 2.2 design, presented by management in R&D webcast

    June 13, 2024
    Press release - Regulatory

    Circio Holding ASA – Bridge financing requested from Atlas

    June 6, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversions of convertible bonds and change of the ratio of subscription rights in the Rights Issue

    June 6, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    June 4, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    June 3, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    May 30, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    May 29, 2024
    Press release - Regulatory

    Circio Holding ASA – Key information relating to the rights issue

    May 29, 2024
    Press release - Regulatory

    Circio Holding ASA – Notice of annual general meeting 2024

    May 29, 2024
    Press release - Regulatory

    Circio announces financing that secures cash runway for twelve months

    May 29, 2024
    Press release - Regulatory

    Circio Holding ASA – Terms of the rights issue and related transactions

    May 13, 2024
    Press release - Non-regulatory

    Circio presents pre-clinical proof-of-concept data for its circVec gene therapy platform at the ASGCT 2024 meeting

    April 29, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    April 25, 2024
    Press release - Regulatory

    Circio Holding ASA: Annual Report 2023

    April 25, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    April 17, 2024
    Press release - Regulatory

    Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus

    April 17, 2024
    Press release - Regulatory

    Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025

    April 17, 2024
    Press release - Regulatory

    Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment

    April 9, 2024
    Press release - Non-regulatory

    Circio invites to a company update on Wednesday 17 April 2024

    March 27, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    March 21, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    March 19, 2024
    Press release - Regulatory

    Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China

    March 13, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    March 8, 2024
    Press release - Regulatory

    Circio Holding ASA: Approval and publication of prospectus

    March 5, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    March 4, 2024
    Press release - Non-regulatory

    The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities

    March 4, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    February 27, 2024
    Press release - Non-regulatory

    Circio to participate in the Annual European Life Sciences CEO Forum in Zürich

    February 7, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    February 5, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    February 1, 2024
    Press release - Non-regulatory

    The first patient has been dosed in Circio’s TG01 triple combination study

    January 22, 2024
    Press release - Non-regulatory

    Circio to present at upcoming conferences

    January 18, 2024
    Press release - Regulatory

    Circio receives waiver of EUR 6.2 million in loans from Business Finland

    January 12, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    January 10, 2024
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    January 4, 2024
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    IR contact
    Dr Erik Digman Wiklund
    Dr Erik Digman Wiklund
    CEO
    erik.wiklund@circio.com
    (+47) 41 33 35 36
    Dr Lubor Gaal
    Dr Lubor Gaal
    CFO & Head of BD
    lubor.gaal@circio.com
    (+34) 683 343 811
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED